AFP and metabolic dysfunction-associated steatotic liver disease: Cox-hazard analysis for prognostic factors of PFS showed elevated ALT (≥ 30 U/L) (HR 1.247, P = 0.029), mALBI grade 2b (HR 1.236, P = 0.047), elevated AFP (≥ 400 ng/mL) (HR 1.294, P = 0.014), and NASH/NAFLD (HR 0.763, P = 0.036) to be significant prognostic factors (Table 3a).